HYDERABAD: Technology start-up incubator T-Hub and leading pharma firm Novartis Healthcare Pvt Ltd Ltd have signed an MoU for creating and executing joint programmes for health tech start-ups from across segments.
In collaboration with the incubator, Novartis will develop plans and programmes that will help health tech, healthcare and pharmaceutical start-ups to scale and grow. Health and research and development experts from Novartis will mentor and guide startups in compliance with T-Hub’s mentorship framework and evaluation process, in their respective ventures, a release on Thursday said. The MoU, to help foster a close relationship in these areas, will contribute to building of a thriving ecosystem in Hyderabad. The Swiss pharma giant Novartis has a significant footprint in India with a strong base in Hyderabad through its Global Drug Development and Business Services Center, the release said.
T-Hub CEO Jay Krishnan said the MoU with Novartis will bring great value to the ecosystem and benefit health tech startups greatly.
Head Global Drug Development India of Novartis Subodh Deshmukh as a global leader in biomedical innovation, the company looked forward to the potential partnership with T-Hub and its allied start-ups to drive innovation in the healthcare space.
